Myeloid-derived Suppressor Cells

MDSC (myeloid-derived suppressor cells) are a heterogenous group of immune cells from the myeloid lineage. MDSCs strongly expand in pathological situations such as chronic infections and cancer, as a result of an altered haematopoiesis. MDSCs are discriminated from other myeloid cell types in which they possess strong immunosuppressive activities rather than immunostimulatory properties.

September 19, 2020
Open Access

NCAPH is negatively associated with Mcl‑1 in non‑small cell lung cancer

Molecular Medicine Reports
Qiuxia XiongYong Duan
September 11, 2020
Open Access

A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade

Proceedings of the National Academy of Sciences of the United States of America
Ivy X ChenRakesh K Jain
September 22, 2020
Open Access

Ramatroban as a Novel Immunotherapy for COVID-19

Journal of Molecular and Genetic Medicine : an International Journal of Biomedical Research
Ajay GuptaSrinivasa T Reddy
September 19, 2020
Review
Open Access

Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy

Cancers
Yufei WangGuangwei Liu
September 19, 2020
Review
Open Access

Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology

Cells
Ernesto BockampDetlef Schuppan
September 10, 2020
Review
Open Access

Pathobiological Interactions of Local Bone Marrow Renin-Angiotensin System and Central Nervous System in Systemic Arterial Hypertension

Frontiers in Endocrinology
Rafiye Ciftciler, Ibrahim Celalettin Haznedaroglu
September 17, 2020
Open Access

Detection of response to tumor microenvironment-targeted cellular immunotherapy using nano-radiomics

Science Advances
Laxman DevkotaRobin Parihar
September 23, 2020

High-Dimensional Analysis of Immune Cell Composition Predicts Periprosthetic Joint Infections and Dissects Its Pathophysiology

Biomedicines
Maximilian F KornFrank A Schildberg
September 15, 2020
Open Access

IL-33 reduces tumor growth in models of colorectal cancer with the help of eosinophils

Oncoimmunology
Melanie KienzlRudolf Schicho
September 17, 2020
Preprint
Open Access

Mitochondrial induced T cell apoptosis and aberrant myeloid metabolic programs define distinct immune cell subsets during acute and recovered SARS-CoV-2 infection

MedRxiv : the Preprint Server for Health Sciences
Elizabeth ThompsonJonathan D Powell
September 18, 2020
Open Access

High M-MDSC Percentage as a Negative Prognostic Factor in Chronic Lymphocytic Leukaemia

Cancers
Michał ZarobkiewiczAgnieszka Bojarska-Junak
September 15, 2020
Open Access

Colon-specific immune microenvironment regulates cancer progression versus rejection

Oncoimmunology
Giulia TrimaglioChristel Devaud
September 11, 2020
Open Access

Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion

Nature Communications
Bianca CioniAndries M Bergman
September 15, 2020
Review

Targeted Microsurgical Denervation of the Spermatic Cord for Chronic Orchialgia: the Current Standard of Care

Current Urology Reports
Sijo Joseph Parekattil

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy: Cancer & Parkinson

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in cancer and Parkinson’s.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Basophils

Basophils are myeloid cells with a high affinity IgE receptor and is involved in inflammatory responses during allergy. Discover the latest research on Basophils here.

© 2020 Meta ULC. All rights reserved
/feed-previews/myeloid-derived-suppressor-cells/975a8b5b-9731-43b8-b1b3-053fac3bbce6